Advertisement

Topics

BioMolecular Therapeutics, Inc. Company Profile

07:24 EDT 20th March 2019 | BioPortfolio

An early-stage biopharmaceutical company, BMT is pioneering the development of novel RNAi therapeutics to prevent and treat age-related macular degeneration based on the company's proprietary technology, asymmetric shorter-duplex siRNA (asiRNA). This novel RNAi technology significantly reduces deleterious side effects triggered by conventional siRNA, especially, the stimulation of the innate immune system, which makes it feasible to use asiRNA for the treatment of age-related macular degeneration, a disease to which RNAi therapeutics could not be developed using conventional siRNAs. Other potential applications for BMT's technology include therapeutics targeting infectious disease, such as herpes simplex virus (HSV), and cancer. A privately held company based in Suwon, South Korea, BMT was established in 2010.


News Articles [817 Associated News Articles listed on BioPortfolio]

RNA Therapeutics: The Triumphant Return Of Biomolecular Mimetics

Polaris Partners launches Dewpoint Therapeutics with $60M round

The company will focus on what it called a previously unexplored field in drug discovery, membrane-less

A Genetic Gold Rush Requires Biomolecular Tools

The post A Genetic Gold Rush Requires Biomolecular Tools appeared first on GEN - Genetic Engineering and Biotechnology News.

Dewpoint launches with $60M series A to target biomolecular condensates

Aromatic 19F-13C TROSY: a background-free approach to probe biomolecular structure, function, and dynamics

Discovering Dewpoint's protein organizers

With biopharma veterans at the helm, Dewpoint launched with a $60M series A to develop its drug discovery platform targeting biomolecular condensates.

Centri-Sep, biotechnology, molecular separations, Panagel, electrophoresis, neuroscience

Leading,manufacturer,of,Centri-Sep,Plasmid-Prep,Panagel,Centri-Spin,Psi-Clone,used,in,DNA,sequencing,electrophoresis,biomolecular,purification

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

AAPS PharmSci 360 is a new conference this year, created in response to a desire for âfresh science,â specifically with chemical and biomolecular components. So what can you expect?

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [596 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

Biomolecular Reaction & Interaction Dynamics Global Environment (BRIDGE).

The pathway from genomics through proteomics and onto a molecular description of biochemical processes make the discovery of drugs and biomaterials possible. A research framework common to genomics an...

Biomolecular charges influence the response of surface plasmon resonance biosensors through electronic and ionic mechanisms.

Surface plasmon resonance (SPR) biosensors have become an important label-free optical biomolecular sensing technology and a "gold standard" for retrieving information on the kinetics of biomolecular ...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Clinical Trials [187 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Effect of Preoperative Music on Sterile Inflammation Induced by Laparoscopic Surgery

Surgery induced sterile inflammation leaves behind a biomolecular footprint measurable by various pro-inflammatory markers e.g. IL-6, CD(Cluster of differentiation)19B, HsCRP(High-sensitiv...

Companies [1331 Associated Companies listed on BioPortfolio]

Centre for Molecular and Biomolecular Informatics

Welcome at the CMBI, which is short for Centre for Molecular and Biomolecular Informatics. The centre performs research and education, and provides services in bioinformatics and cheminformatics.

Association of Biomolecular Resource Facilities

The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication, and education.

BioMolecular Therapeutics, Inc.

An early-stage biopharmaceutical company, BMT is pioneering the development of novel RNAi therapeutics to prevent and treat age-related macular degeneration based on the company's proprietary technolo...

Affigen

Affigen (www.affigen.com) develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers. The Company's growing team ...

Aquasome

A platform nanoparticulate technology for biomolecular delivery in a broad range of industrial, personal use, and biomedical applications.

More Information about "BioMolecular Therapeutics, Inc." on BioPortfolio

We have published hundreds of BioMolecular Therapeutics, Inc. news stories on BioPortfolio along with dozens of BioMolecular Therapeutics, Inc. Clinical Trials and PubMed Articles about BioMolecular Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMolecular Therapeutics, Inc. Companies in our database. You can also find out about relevant BioMolecular Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record